CAS: 25137-01-3; (R)-Ethyl Piperidine-3-Carboxylate

该化合物是一种常见的模型,在CNS活性剂,藻类和其他含氮的外生循环的开发中为该化合物提供了效用;其稳定性和定义明确的立体化学学确保了合成应用中的再生.

结构式图片

相似化合物

37675-19-7 37675-18-6 5006-62-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号71962-74-8 呱啶乙酯 | CAS号614-18-6 烟酸乙酯 | CAS号145821-58-5 噻加宾乙酯 | CAS号205194-11-2 (R)-(1-甲基哌啶-3-基)甲醇 | CAS号191092-07-6 (R)-3-(甲苯磺酰氧基甲基... | CAS号205194-12-3 1-甲基哌啶-3-羧酸-(R)-乙酯 | CAS号155541-67-6 (R)-tert-butyl ... | CAS号140645-24-5 (S)-1-B°C-3-氨甲基哌啶 | CAS号194726-40-4 (R)-1-叔丁氧羰基-3-哌啶甲酸乙酯 | CAS号71962-74-8 呱啶乙酯

合成工艺路线路线简述

  • 合成目标产物 Ethyl (3R)-Piperidine-3-Carboxylate 主要起始原料 Ethyl Nicotinate
  • (文献来源)合成步骤主要原料 Ethyl Nicotinate
3-哌啶甲酸乙酯置于potassium Carbonate体系中,用 水,异丙醇 用作溶剂,化学反应生成(R)-3-哌啶甲酸乙酯
参考文献:A Practical Synthesis Of The Platelet Fibrinogen Antagonist,Elarofiban
标题:A Practical Synthesis Of The Platelet Fibrinogen Antagonist,Elarofiban
摘要:Elarofiban Is A Novel,Nonpeptide,Orally Active Fibrinogen Receptor Antagonist Useful For The Treatment Of Platelet Mediated Thrombotic Disorders (Costanzo,M. J.; Hoekstra,W. J.; Maryanoff,B. E. Wo,97/41102,1997). Herein We Describe The Process Research That Was Carried Out For The Synthesis Of Elarofiban That Eventually Led To The Development Of A Safe And Cost-Effective Commercial Scale Process.
Doi:10.1021/op034103O

海关参考信息

专利信息


专利号:US-5220016-A
优先权日:1991-07-29
标 题:Synthesis of navelbine analogs
发明人:MAGNUS PHILIP D; THURSTON LEE S
权利人:UNIV TEXAS
摘要:The invention is a de novo synthesis of the norcatharanthine moiety of navelbine. The synthesis includes condensing a Grignard reagent prepared from an amine-protected R(+)-piperidinyl methanol with an N-protected 2-methoxyoxalyl indole. The indole N-protecting group is removed to provide a 2-methoxyindole hydroxy ester which is coupled to vindoline. After removal of the amineprotecting group from the piperidinyl group, ring closure to the indole moiety provides dihydrodesethyl navelbine. Other derivatives and analogs of navelbine with potential clinical applications in cancer chemotherapy may be readily synthesized. The synthesis opens a route to a wide variety of navelbine modifications, including modifications at or near the tryptamine bridge.

专利号:US-7692019-B2
优先权日:2000-12-04
标 题:Methods for the stereoselective synthesis of substituted piperidines
发明人:AQUILA BRIAN M; BANNISTER THOMAS D; CUNY GREGORY D; HAUSKE JAMES R; HEFFERNAN MICHELE L R; HOEMANN MICHAEL Z; KESSLER DONALD W; SHAO LIMING; WU XINHE; XIE ROGER L
权利人:SEPRACOR INC
摘要:One aspect of the present invention relates to methods of synthesizing substituted piperidines. A second aspect of the present invention relates to stereoselective methods of synthesizing substituted piperidines. The methods of the present invention will find use in the synthesis of compounds useful for treatment of numerous ailments, conditions and diseases that afflict mammals, including but not limited to addiction and pain. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the substituted piperidines using the methods of the present invention. An additional aspect of the present invention relates to enantiomerically substituted pyrrolidines, piperidines, and azepines.

专利号:WO-2024185775-A1
优先权日:2023-03-06
标 题:Long-chain alkenyloxy–substituted benzoyl derivative and oligonucleotide synthesis method using same
发明人:OKADA YOHEI; INANAGA KAZATO; SHOJI Yukiya; MIZUFUNE HIDEYA; SUDO TATSUYA; ADACHI Sota; HOSOI Kazushi
权利人:SPERA PHARMA INC; TOKYO UNIV OF AGRICULTURE AND TECHNOLOGY
摘要:The purpose of the present invention is to provide a novel pseudo–solid phase protecting group that can be used in liquid-phase oligonucleotide synthesis. The purpose of the present invention is also to provide an oligonucleotide synthesis method that uses a novel pseudo–solid phase protecting group. The present invention provides a compound represented by formula (1) (in which R represents a C14–60 alkenyl group, n represents 2 or 3, m represents 0 or 1, p represents 1 or 2, X represents C, N, O, or S, Y represents a single bond or B(CH 2 ) t * or may form a ring with X, and Z represents a single bond or (CH 2 ) s (s being an integer from 1 to 5)). The present invention also provides an oligonucleotide production method that uses the compound.

专利号:US-7816375-B2
优先权日:2000-09-11
标 题 :Ligands for monoamine receptors and transporters, and methods of use thereof
发明人:AQUILA BRIAN M; BANNISTER THOMAS D; CUNY GREGORY D; HAUSKE JAMES R; HOLLAND JOANNE M; PERSONS PAUL E; RADEKE HEIKE; WANG FENGJIANG; SHAO LIMING
权利人:SEPRACOR INC
摘要:One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian cellular receptors, including dopamine, serotonin, or norepinephrine transporters. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, schizophrenia, Parkinson's disease, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, and Tourette's syndrome. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds, and the screening of those libraries for biological activity, e.g., in assays based on dopamine transporters.

专利号:US-2002177721-A1
优先权日:2000-12-04
标题 :Methods for the stereoselective synthesis of substituted piperidines

专利号:US-2006211864-A1
优先权日:2000-12-04
标题:Methods for the stereoselective synthesis of substituted piperidines
上海齐奥化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.qiaochem.com
企业联系电话:021-50396381;50940968;58892003👤
📞上海齐奥化工科技有限公司 ⚠️参考联系方式
联系人:徐先生
电话:021-50396381;50940968;58892003

传真:021-50396382
邮箱:aaron@qiaochem.com
通信地址: 上海浦东新区张江环科路515号1号楼910室
邮编: 201315
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海浦东新区张江环科路515号1号楼910室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
万邦德制药集团股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chemphar.com
电话: 86-0576-86183883👤
📞万邦德制药集团股份有限公司 ⚠️参考联系方式

销售电话:86-0576-86183883
邮箱:wltdfc@mail.tzptt.zj.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
安徽德信佳生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jndxj.com
电话:0531-82375880,0531-82375892👤
📞 安徽德信佳生物医药有限公司⚠️参考联系方式

电话: 0531-82375880,0531-82375892
邮件:sales02@jndxj.com
网址: http://www.jndxj.com
地址:安徽省阜阳市太和县经济开发区和谐大道9号
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

安徽省阜阳市太和县经济开发区和谐大道9号
⚠️ 未注册 · 未认证企业
注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: A M Rustum, Et Al. Separation Of The S(+) And R(-)-Enantiomers Of Tiagabine.Hcl And Its Two Chiral Precursors By Chiral Chromatography: Application To Chiral Inversion Studies. J Pharm Biomed Anal. 1998 Sep;17(8):1439-47.
[参考文献]: J-H Hu, Et Al. Up-Regulation Of Gamma-Aminobutyric Acid Transporter I Mediates Ethanol Sensitivity In Mice. Neuroscience. 2004;123(4):807-12.
[参考文献]: M Potegal, Et Al. Differential Effects Of Ethyl (R,S)-Nipecotate On The Behaviors Of Highly And Minimally Aggressive Female Golden Hamsters. Psychopharmacology (Berl). 1986;89(4):444-8.
[参考文献]: S H Zorn, Et Al. (R)-Nipecotic Acid Ethyl Ester: A Direct-Acting Cholinergic Agonist That Displays Greater Efficacy At M2 Than At M1 Muscarinic Receptors. J Pharmacol Exp Ther. 1987 Jul;242(1):173-8.
[参考文献]: T Andree, Et Al. Thip Analgesia: Cross Tolerance With Morphine. Life Sci. 1983 May 9;32(19):2265-72.

合成参考文献


参考文献:10.1007/s11696-023-03176-6
摘要:Bhavsar S, Joshi S, Deshmukh V, Pawar S, Dond B, Mishra A, Kayastha AK, Yeole R, Deshpande P, Bhagwat S, Patel M. Design and development of an efficient convergent synthetic strategy for novel β-lactam enhancer zidebactam (WCK 5107). Chem. Pap. 2023 Nov 12;78(3):1493–504. doi: 10.1007/s11696-023-03176-6.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知